Regarding PRC1, its oncogene member BMI1, a downstream target of the BCR–ABL1 tyrosine kinase, was identified as a possible prognostic marker in CML (42, 43). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.